The efficacy and safety of sodium-glucose cotransporter inhibitors in cancer patients with heart failure-a single-centre experience

Kardiol Pol. 2024;82(3):327-329. doi: 10.33963/v.phj.98946. Epub 2024 Feb 13.

Authors

Katarzyna Styczkiewicz^{1

2}, Andrzej Sokołowski³

Affiliations

¹ Institute of Medical Sciences, Medical College, University of Rzeszow, Rzeszów, Poland. kstyczkiewicz@ur.edu.pl.
² Subcarpathian Oncological Centre, Frederic Chopin University Clinical Hospital, Rzeszów, Poland. kstyczkiewicz@ur.edu.pl.
³ Collegium Humanum - Warsaw Management University, Warszawa, Poland.

PMID: 38348615
DOI: 10.33963/v.phj.98946

No abstract available

MeSH terms

Diabetes Mellitus, Type 2*
Glucose
Heart Failure* / complications
Heart Failure* / drug therapy
Humans
Neoplasms* / complications
Neoplasms* / drug therapy
Sodium

Substances

Glucose
Sodium